読み込み中
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
前日終値
$21.65
−$0.11 · -0.51%
日中の時刻はETです。市場データは遅延する場合があります。
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
日中レンジ
現在 $21.65
52週レンジ
現在 $21.65
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
中立
バリュエーション
47
適正価値
センチメント
62
強気
リスク
43
やや高いリスク
モメンタム
53
中立
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
OrthoPediatrics Corp. is a medical technology firm dedicated to the design, development, and global commercialization of specialized implants and devices. These products are meticulously crafted to be anatomically appropriate for treating children affected by orthopedic conditions across the United States and internationally. The company's diverse offerings span products for trauma and deformity correction, surgical systems for spinal deformities such as scoliosis, and solutions for sports medicine, among others. Their comprehensive product line features items like PediLoc, PediPlates, various cannulated screws, the PediFlex and PediNail systems, PediLoc tibia, advanced anterior cruciate ligament reconstruction systems, specialized locking cannulated blades and proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, the Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and the ApiFix Mid-C system. OrthoPediatrics Corp. primarily serves the pediatric orthopedic market, directly assisting pediatric orthopedic surgeons and caregivers. The company was founded in 2006 and maintains its headquarters in Warsaw, Indiana.
日中レンジ
現在 $21.65
52週レンジ
現在 $21.65
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 2.36億 USD | 2.05億 USD | 1.49億 USD | 1.22億 USD | 9804.9万 USD |
| 売上原価 | 6368.7万 USD | 5612.9万 USD | 3747.9万 USD | 3162.9万 USD | 2464.6万 USD |
| 粗利益 | 1.73億 USD | 1.49億 USD | 1.11億 USD | 9066万 USD | 7340.3万 USD |
| 研究開発 | 910.2万 USD | 1103.4万 USD | 1089.5万 USD | 845.2万 USD | 554.3万 USD |
| 販売・一般管理 | 1.93億 USD | 1.67億 USD | 1.26億 USD | 1.04億 USD | 8573.4万 USD |
| 営業費用 | 2.02億 USD | 1.78億 USD | 1.38億 USD | 1.16億 USD | 9142.7万 USD |
| 受取利息 | — | — | 19.8万 USD | — | — |
| 支払利息 | 599.6万 USD | 262.1万 USD | — | 242.4万 USD | 224.7万 USD |
| 減価償却費と償却費 | 2111.9万 USD | 1908万 USD | 1738.5万 USD | 1309.9万 USD | 1068万 USD |
| 営業利益 | −2899.9万 USD | −2952.1万 USD | −2675.1万 USD | −2539.9万 USD | −1802.4万 USD |
| 純利益 | −3964.8万 USD | −3782.2万 USD | −2097.4万 USD | 125.8万 USD | −1626万 USD |
会社概要が更新されました 2026年10月11日.
直近の発表実績
直近の発表実績
第三者のアナリスト予想は変更される場合があり、GoAIの推奨ではありません。
この株式へのエクスポージャーを報告している上場投資信託です。
Vanguard Morningstar Total Stock Market ETFVTI1245.45万0.00%2.3兆 USD0.03%$381.94+0.63%
iShares Russell 2000 ETFIWM1012.87万0.01%787.4億 USD0.19%$278.94+0.49%
Vanguard Extended Market ETFVXF466.82万0.00%954億 USD0.05%$235+0.80%
Dimensional - US Small Cap ETFDFAS322.46万0.01%338.69億 USD0.31%$78.35+0.32%
Vanguard Russell 2000 ETFVTWO236.64万0.01%180億 USD0.06%$112.66+0.50%
Schwab U.S. Small-Cap ETFSCHA199.43万0.01%218.24億 USD0.03%$32.79+0.40%
Dimensional - US Core Equity 2 ETFDFAC170.57万0.00%885.96億 USD0.21%$45.33+0.49%
U.S. Micro Cap Portfolio ETFDFMC151.59万0.02%75.58億 USD0.43%$57.813+0.20%Vanguard Morningstar Total Stock Market ETFVTIiShares Russell 2000 ETFIWMVanguard Extended Market ETFVXFDimensional - US Small Cap ETFDFASVanguard Russell 2000 ETFVTWOSchwab U.S. Small-Cap ETFSCHADimensional - US Core Equity 2 ETFDFACU.S. Micro Cap Portfolio ETFDFMCAIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。
